OakChart

LivaNova PLC

LIVNHealthcare·Medical Devices·United Kingdom·Mid·NASD·Nov 11 • 12:01 PM ET

90.52-0.62 (-0.68%)
2026-11-11 18:01 CET
Market cap
5,020.61 USD m
Revenue, TTM
1,506.89 USD m
Net income, TTM
196.05 USD m
Free cash flow, TTM
129.02 USD m
EPS diluted, TTM
3.48
P/E
25.99
Compare

Price

LIVN against its 20, 50 and 200-day averages
2050200beatmiss
60.0070.0080.0090.00100.001.9M3.8MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26LIVNclose 90.5220-day 83.3150-day 79.95200-day 73.9190.5252w high

8.9% under the 52-week high of 99.38 on 4 Nov 2026. 52-week low 51.11 on 11 Nov 2025. Last 15 sessions, 26.8% high to low

Profile

LIVN
52-week range, 82% of the way up
51.1199.38

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.

IndexRUT
Employees3300
IPOFeb 11, 1993
Beta0.90
ATR, 14d3.40
Rel volume0.31
Short float11.60%
Insider own0.41%
Inst own113.18%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap4.99B
Enterprise Value4.78B
Income196.05M
Sales1.51B
Book/sh24.91
Cash/sh10.23
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees3300
IPOFeb 11, 1993

Ratios

P/E25.99
Forward P/E19.14
PEG1.91
P/S3.31
P/B3.63
P/C8.85
P/FCF38.65
EV/EBITDA16.24
EV/Sales3.17
Quick Ratio1.22
Current Ratio1.46
Debt/Eq0.26
LT Debt/Eq0.25
Option/ShortYes / Yes

Earnings

EPS (ttm)3.48
EPS next Y4.73
EPS next Q0.97
EPS this Y13.71%
EPS next Y6.66%
EPS next 5Y10.02%
EPS past 3/5Y-40.20% 9.06%
Sales past 3/5Y10.75% 8.24%
EPS Y/Y TTM189.30%
Sales Y/Y TTM11.71%
EPS Q/Q23.11%
Sales Q/Q9.89%
EarningsNov 04 BMO
EPS/Sales Surpr.16.08% 3.14%

Ownership

Insider Own0.41%
Insider Trans-5.49%
Inst Own113.18%
Inst Trans-0.26%
ROA7.44%
ROE15.50%
ROIC11.42%
Gross Margin68.19%
Oper. Margin15.14%
Profit Margin13.01%
SMA208.66%
SMA5013.21%
SMA20022.47%
Trades-

Technical

Shs Outstand55.09M
Shs Float54.86M
Short Float11.60%
Short Ratio9.45
Short Interest6.36M
52W High99.38 -8.92%
52W Low51.11 77.11%
Volatility5.19% 3.46%
ATR (14)3.40
RSI (14)64.70
Beta0.90
Rel Volume0.31
Avg Volume673.55K
Volume88,211

Performance

Perf Week-3.90%
Perf Month18.53%
Perf Quarter10.12%
Perf Half Y24.96%
Perf YTD47.12%
Perf Year71.83%
Perf 3Y97.64%
Perf 5Y1.83%
Perf 10Y117.07%
Recom1.75
Target Price108.10
Prev Close91.14
Price90.52
Change %-0.68%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 07, 2026InitiatedBBarclaysOverweight$105+16.0%
Dec 19, 2025InitiatedKKeyBanc Capital MarketsOverweight$81-10.5%
Oct 01, 2025DowngradeGGoldmanBuy → Neutral$55-39.2%
May 20, 2025UpgradeWWolfe ResearchPeer Perform → Outperform$60-33.7%
Feb 26, 2025DowngradeWWolfe ResearchOutperform → Peer Perform
Oct 04, 2024InitiatedGGoldmanBuy$65-28.2%
Sep 17, 2024UpgradeRRobert W. BairdNeutral → Outperform$55 → $66-27.1%
Mar 20, 2024ReiteratedNNeedhamBuy
Feb 20, 2024UpgradeMMizuhoNeutral → Buy$60 → $70-22.7%
Sep 06, 2023InitiatedHHSBC SecuritiesHold$52-42.6%

Peers

Mkt cap
TickerCompanyMkt cap
MDTMedtronic Plc129.32B
NPCENeuroPace Inc441.75M
INSPInspire Medical Systems Inc1.78B
BSXBoston Scientific Corp66.20B
ABTAbbott Laboratories190.22B
TMDXTransmedics Group Inc3.23B
HAEHaemonetics Corp5.53B
ECORElectroCore Inc76.80M
ITGRInteger Holdings Corp4.31B
STIMNeuronetics Inc129.03M

Insider trading

latest 14 of 36
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Bianchi FrancescoDirectorSep 10 '26Sale78.013,500273,0324,434Sep 14 04:23 PM
Bianchi FrancescoOfficerSep 10 '26Proposed Sale78.013,500273,032Sep 10 04:27 PM
Story BrookeDirectorSep 04 '26Sale81.422,300187,2707,488Sep 08 05:01 PM
Story BrookeOfficerSep 04 '26Proposed Sale81.422,300187,270Sep 04 04:15 PM
Poletti FrancoOfficerSep 02 '26Proposed Sale82.0910,755882,888Sep 02 04:24 PM
Bianchi FrancescoDirectorAug 31 '26Sale79.721,650131,5387,934Sep 02 04:19 PM
Bianchi FrancescoOfficerAug 31 '26Proposed Sale79.721,650131,538Aug 31 04:12 PM
Tezel AhmetChief Innovation OfficerAug 11 '26Option Exercise52.6812,692668,61518,782Aug 13 04:04 PM
Tezel AhmetChief Innovation OfficerAug 11 '26Sale77.742,675207,9426,090Aug 13 04:04 PM
Tezel AhmetOfficerAug 11 '26Proposed Sale78.482,675209,942Aug 11 04:12 PM
WILVER PETER MDirectorJun 15 '26Option Exercise0.004,042010,780Jun 17 04:09 PM
SCHERMERHORN TODD CDirectorJun 15 '26Option Exercise0.004,042013,105Jun 17 04:09 PM
Bianchi FrancescoDirectorJun 15 '26Option Exercise0.004,042011,270Jun 17 04:09 PM
Bianchi FrancescoDirectorJun 15 '26Sale80.191,20096,2289,584Jun 17 04:09 PM

Held by

AUM
TickerCompanyAUM
IJHiShares Core S&P Mid-Cap ETFAUM: 124.48B
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFATU.S. Targeted Value Portfolio-ETF Class Shares-
XMMOInvesco S&P MidCap Momentum ETFAUM: 6.37B
XMHQInvesco S&P MidCap Quality ETFAUM: 5.81B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
MDYState Street SPDR S&P MIDCAP 400 ETF TrustAUM: 26.22B
DFASU.S. Small Cap Portfolio-ETF Class Shares-

News

latest 14 of 206
  • LivaNova Beats And Raises A Third Time As Epilepsy Accelerates, But Flat Cash Guidance And A Q4 Reset Temper The Upgrade (Earnings Whispers) +17.88%
  • LivaNova: Q3 Earnings Snapshot (Associated Press)
  • LivaNova Reports Third-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance (Business Wire)
  • LivaNova Tests Its Guidance Ladder As Street Estimates Trail The Company's Raised Outlook (Earnings Whispers)
  • Neuromodulation Publishes Full 36-Month CORE-VNS Results Demonstrating Sustained and Increasing Benefits of LivaNova's VNS Therapy for Drug-Resistant Epilepsy (Business Wire)
  • Loading…
  • LivaNova to Present at UBS, Wolfe, Stifel, and Jefferies Healthcare Conferences in November (Business Wire)
  • Stephen K. Brannan, MD, and John D. Young Appointed to Slate Medicines Board of Directors (Exec Edge)
  • Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls (The Fly)
  • LivaNova to Announce Third-Quarter 2026 Results (Business Wire)
  • LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September (Business Wire)
  • LivaNova PLC (LIVN) (Q2 2026) Earnings Call Highlights: Record Revenue and EPS, Raised Guidance ... (GuruFocus.com) -8.41%
  • LivaNova exceeds second-quarter forecasts and increases 2026 outlook (InvestorsHub)
  • LivaNova: Q2 Earnings Snapshot (Associated Press)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-041.2301.0600.110393.1381.1310
2026Q22026-08-051.2601.0951.929390.6380.59
2026Q12026-05-060.9800.8970.399362.3346.0510
2025Q42026-02-250.8600.8150.557360.9353.310
2025Q32025-11-051.1100.9190.486357.8342.79
2025Q22025-08-061.0500.8670.497352.5332.229
2025Q12025-05-070.8800.762-6.015316.9302.429
2024Q42025-02-250.8100.8011.022321.8324.149
2024Q32024-10-300.9000.7170.604318.1300.419
2024Q22024-07-310.9300.7830.299315.6304.788
2024Q12024-05-010.7300.486-0.777290.8278.178
2023Q42024-02-210.8700.7700.300310.1287.718
2023Q32023-11-010.7300.636-0.136286.1271.978
2023Q22023-07-260.7800.5390.021293.9265.058
2023Q12023-05-030.4300.3930.137263.4243.337
2022Q42023-02-220.8100.7330.031274.9262.296

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY3.0803.062-3.2101,0841,092
2020FY1.2701.227-7.148934.2933.39
2021FY2.0702.078-2.6821,0351,032
2022FY2.3902.322-1.6131,0221,009
2023FY2.8002.7060.3241,1501,132
2024FY3.3803.3691.1591,2531,256
2025FY3.9003.862-4.4501,3881,380
2026FY-4.435--1,534
2027FY-4.730--1,644
2028FY-5.193--1,767
2029FY-6.205--1,961
2030FY-7.980--2,301

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-04901389.18385.7394.2
2026Q4S2026-11-02900390.25386394.95
2026Q4S2026-10-19910390.25386394.95
2026Q4S2026-10-12940390.25386394.95
2026Q4S2026-10-09930390.24386394.9
2026Q4S2026-08-19940390.25386395
2026Q4S2026-08-05930389.35386395
2026Q4S2026-07-22900387.34384.6392
2026Q4S2026-07-20900387.33384.6392
2026Q4S2026-07-14901387.33384.6392
2026Q4S2026-07-131001387.13384.6392
2026Q4S2026-06-291001387.33384.6392
2026Q4S2026-05-26901387.47384.6392
2026Q4S2026-05-13901387.36384.6392

Estimate history

EPS, annual-0.521-3.901-3.21-7.148-2.682-1.6130.3241.159-4.4453.4823
Period201720182019202020212022202320242025TTM
EPS, quarterly0.6041.022-6.0150.4970.4860.5570.3991.9290.598
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1012.2771106.9611084.17934.2411035.3651021.8051153.5451253.4371388.0531506.89
Period201720182019202020212022202320242025TTM
Sales, quarterly318.12321.8316.855352.524357.753360.9362.258390.587393.148
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual48.28748.20648.44448.65653.26353.56553.91854.34954.64955.085
Period201720182019202020212022202320242025MRQ
Shares, quarterly54.354.34954.52354.5954.60554.64954.90155.05255.085
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,506.891,388.051,253.441,153.551,021.801,035.37934.241,084.171,106.96
Cost of Goods Sold Incl. D&A479.32443.98381.26368.10304.08328.81359.94379.79409.69
Gross Profit1,027.57944.07872.17785.45717.73706.56574.30704.38697.27
Selling, General and Administrative Excl. Other798.37730.98687.09684.15595.40641.13598.48654.36605.64
Research and Development201.14182.16180.51166.02136.42166.81152.90149.89146.02
Other Operating Expense1.08-12.0319.642.350.621.7853.44-0.600.00
Operating Income228.13225.13165.4498.95121.7163.65-77.6250.6291.64
Interest Expense34.3249.2963.0759.3948.2050.1540.8415.009.76
Unusual Expense132.78417.6540.35144.54145.01130.97235.19214.32336.87
Net Income Before Taxes120.34-220.7888.31-81.23-75.14-124.47-348.02-185.69-247.45
Income Taxes-76.7721.6425.06-98.8811.0511.20-0.96-30.15-69.63
Consolidated Net Income196.05-242.4763.2317.55-86.25-135.82-347.33-155.54-178.46
Net Income From Continuing Operations196.05-242.4763.2317.55-86.25-135.82-347.33-155.54-178.46
Net Income196.05-242.4763.2317.55-86.25-135.82-347.33-155.18-189.19
EPS (Recurring)5.040.911.682.190.29-0.87-3.76-0.110.96
EPS (Basic, Before Extraordinaries)3.57-4.451.170.33-1.61-2.68-7.15-3.21-3.90
EPS (Diluted)3.48-4.451.160.32-1.61-2.68-7.15-3.21-3.90
EBITDA294.42284.76216.58159.81179.51131.643.70133.61161.58
Non-Operating Income (Expense)59.4121.0326.2923.75-3.65-7.015.63-7.007.55
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense38.7933.4831.3027.2644.1039.9834.1025.9619.72
Price To Earnings Ratio26.1726.17108.66965.30-----
Price To Sales Ratio2.912.422.022.432.914.283.443.364.01
Gross Margin68.1968.0169.5868.0970.2468.2461.4764.9762.99
Operating Margin15.1416.2213.208.5811.916.15-8.314.678.28
Net Margin13.01-17.475.041.52-8.44-13.12-37.18-14.31-17.09
Shares Outstanding55.0954.6554.3553.9253.5653.2648.6648.4448.21
Market Capitalization5,020.615,020.612,514.672,787.282,972.654,653.513,217.573,650.814,453.22

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue393.15390.59362.26360.90357.75352.52316.86321.80
Cost of Goods Sold Incl. D&A124.90115.92117.41121.10112.90113.5496.08102.50
Gross Profit268.25274.67244.85239.80244.85238.99220.78219.30
Selling, General and Administrative Excl. Other202.61210.99192.66192.10187.10184.97171.55178.60
Research and Development47.6952.8649.0951.5048.5847.1937.8843.30
Other Operating Expense0.001.080.000.00-0.62-0.080.003.30
Operating Income65.6462.6052.1947.7058.3754.1149.2337.40
Interest Expense7.957.188.2910.9010.8612.2815.2915.80
Unusual Expense16.3651.9521.6742.7917.48-3.35345.96-32.16
Net Income Before Taxes46.7718.4827.4827.6033.9133.32-315.6556.50
Income Taxes12.40-90.204.34-3.307.116.1511.660.60
Consolidated Net Income34.29108.5722.2930.8926.7827.16-327.3255.90
Net Income From Continuing Operations34.29108.5722.2930.8926.7827.16-327.3255.90
Net Income34.29108.5722.2930.8926.7827.16-327.3255.90
EPS (Recurring)0.802.580.671.100.710.45-1.560.61
EPS (Basic, Before Extraordinaries)0.621.980.410.570.490.50-6.011.03
EPS (Diluted)0.601.930.400.560.490.50-6.011.02
EBITDA83.4380.8067.7862.4173.5969.1563.9049.98
Non-Operating Income (Expense)5.4515.015.2633.693.89-11.86-3.622.74
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense11.5013.346.537.437.867.256.155.53
Price To Earnings Ratio26.1742.45----34.21108.66
Price To Sales Ratio2.913.142.482.462.141.881.682.03
Gross Margin68.2370.3267.5966.4468.4467.7969.6868.15
Operating Margin16.7016.0314.4113.2216.3215.3515.5411.62
Net Margin8.7227.806.158.567.497.70-103.3017.37
Shares Outstanding55.0955.0554.9054.6554.6154.5954.5254.35
Market Capitalization5,020.614,517.183,476.093,359.882,860.012,454.752,134.942,514.67

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments635.55723.56577.87515.62207.99252.8361.1447.2093.61
Short Term Receivables215.99193.16215.07183.11203.05185.16258.37256.74282.14
Inventories164.70147.57147.89129.38105.84115.28164.15153.53144.47
Other Current Assets85.3862.9147.3357.53162.29154.7765.7875.82349.63
Total Current Assets1,101.611,127.19988.16885.64679.18708.04549.44533.30869.86
Net Property, Plant & Equipment298.12217.10205.03183.02190.67214.33235.73191.40192.36
Total Investments and Advances56.8448.8261.3470.6616.60103.4027.2627.4538.44
Long-Term Note Receivable-------0.001.28
Intangible Assets1,022.80987.301,044.121,137.351,299.211,359.951,523.341,727.251,319.64
Deferred Tax Assets110.98111.86118.861.382.202.9968.6868.1511.56
Other Assets15.6914.1312.0616.7313.1011.257.362.1570.77
Total Assets2,606.052,506.392,429.562,294.772,200.952,399.962,411.802,549.702,503.89
Short Term Debt Incl. Current Port. of LT Debt40.2687.0426.4732.81240.9324.6288.5128.7984.03
Accounts Payable97.1669.7380.8474.3168.0073.6785.8976.7385.92
Income Tax Payable33.1332.4623.3416.5015.1416.4612.7222.5312.83
Other Current Liabilities637.52202.90204.32173.77372.90194.30325.44368.69223.24
Total Current Liabilities808.07392.12334.98297.40696.97309.05512.55496.75406.02
Long Term Debt393.51589.73613.93547.6245.77684.52306.36139.5461.96
Provision for Risks Charges3.052.923.103.0193.4589.85138.77138.518.00
Deferred Tax Liabilities9.5910.9111.578.527.737.0932.2268.19123.34
Other Liabilities191.84190.44188.35230.6162.38200.1938.18202.9889.26
Total Liabilities1,406.071,186.131,151.931,087.15906.311,290.701,028.081,045.96688.58
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,199.991,320.261,277.631,207.621,294.641,109.271,383.721,503.741,815.31
Total Shareholders Equity1,199.991,320.261,277.631,207.621,294.641,109.271,383.721,503.741,815.31
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity1,199.991,320.261,277.631,207.621,294.641,109.271,383.721,503.741,815.31
Total Liabilities & Stockholders Equity2,606.052,506.392,429.562,294.772,200.952,399.962,411.802,549.702,503.89
Book Value Per Share21.9624.2923.7022.5524.3122.8028.5631.1937.59
Tangible Book Value Per Share3.246.134.331.31-0.09-5.15-2.88-4.6410.27
Full-Time Employees3,3002,9002,9002,9003,0004,0004,0004,0004,500
Price to Book Ratio3.661.922.272.593.602.882.642.932.01
Return on Assets-9.492.560.74-3.84-5.89-14.44-6.27-7.062.25
Return on Equity-19.244.871.41-6.89-11.25-27.86-10.77-10.753.09
Return on Invested Capital-15.223.310.93-4.91-10.13-19.36-9.18-11.51-1.34
Quick Ratio1.162.502.512.540.821.920.750.761.79
Current Ratio1.362.872.952.980.972.291.071.072.14

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income196.06-242.4763.2317.55-86.25-135.82-348.82-155.18-189.40
Depreciation66.2959.6351.1460.8657.8067.9981.3282.9969.94
Other Funds (Non Cash)110.6266.7560.56145.56128.66135.85258.02196.0729.71
Funds from Operations282.48-115.63181.73109.53101.6170.8727.5997.60-184.80
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-44.61369.971.31-34.62-31.6929.22-107.01-188.75305.29
Income Taxes Payable-1.27-3.5910.857.361.380.103.60-8.44-
Cash from Operating Activities237.86254.34183.0474.9169.92100.09-79.42-91.14120.49
Capital Expenditures-108.85-81.05-47.11-34.98-26.52-25.48-35.02-27.98-38.00
Net Assets From Acquisitions0.000.000.000.00-8.86-1.69-1.72-10.75-279.69
Sale of Fixed Assets and Businesses7.287.280.000.000.0042.950.001.26200.90
Purchase or Sale of Investments1.290.86-1.14-6.50-2.9519.40-3.18-2.50-3.77
Purchase of Investments-7.78-5.67-1.14-6.50-2.95-3.65-3.18-2.50-3.77
Sale Or Maturity of Investments9.076.520.000.000.0023.060.000.000.00
Other Uses0.360.000.000.00-0.090.00-1.92-1.320.00
Other Sources0.060.000.091.150.001.730.000.000.00
Cash from Investing Activities-99.86-72.91-48.16-40.33-38.4136.90-41.84-41.29-120.56
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-12.53-4.39-11.210.000.00322.56-43.104.84-45.82
Repurchase of Common Pref Stock-12.53-4.43-40.080.000.000.00-43.100.00-50.00
Sale of Common Pref Stock0.000.0428.860.000.00322.560.004.844.18
Proceedsfrom Stock Options0.000.0022.520.000.00322.560.004.470.00
Issuance or Reduction of Debt, Net-160.05-280.9382.0326.40280.71-487.85383.31167.9729.00
Change in Long Term Debt-160.05-280.9382.0328.38280.71-487.85381.10169.1679.74
Issuance of Long Term Debt0.000.00329.5750.00504.250.00863.16193.37103.57
Reduction of Long Term Debt-160.05-280.93-247.55-21.62-223.54-487.85-482.06-24.21-23.83
Net Financing Active Other Cash Flow-43.92-0.34-52.27-4.92-0.58-13.74-29.46-26.23-25.52
Other Financing Activities Uses-48.40-0.34-52.70-7.50-8.67-18.19-32.51-26.23-25.52
Cash from Financing Activities-216.50-285.6618.5521.48280.13-179.03310.76146.58-42.35
Exchange Rate Effect-4.1216.23-7.756.19-4.01-2.812.21-0.22-4.00
Net Change in Cash-82.61-88.00145.6862.25307.63-44.84191.6913.93-46.41
Free Cash Flow129.02173.29135.9339.9343.4074.62-114.45-115.8382.49
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow34.0219.3718.5970.2468.4259.33--53.78
Deferred Taxes & Investment Tax Credit-0.466.79-114.431.412.8537.07-26.28-95.05

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments563.47516.62539.71635.55646.08593.64
Short Term Receivables236.37231.30229.27215.99211.58220.19
Inventories177.88172.61165.50164.70167.54165.35
Other Current Assets105.13104.5179.7585.3871.9586.96
Total Current Assets1,082.851,025.051,014.241,101.611,097.151,066.14
Net Property, Plant & Equipment350.00330.05310.01298.12269.71246.09
Total Investments and Advances69.3972.5656.7756.8443.0637.82
Intangible Assets989.53996.151,010.151,022.801,025.561,032.51
Deferred Tax Assets194.45198.75109.82110.98107.31109.81
Other Assets26.8918.3115.3715.6914.8014.33
Total Assets2,713.122,640.862,516.352,606.052,557.582,506.70
Short Term Debt Incl. Current Port. of LT Debt13.0812.3711.5940.2694.4491.51
Accounts Payable106.91103.3999.1597.1688.1686.93
Income Tax Payable28.9022.0741.7033.1321.3734.49
Other Current Liabilities591.30569.17610.04637.52623.62614.16
Total Current Liabilities740.19707.00762.48808.07827.59827.10
Long Term Debt343.99339.58331.86393.51392.11391.27
Provision for Risks Charges61.7545.0946.143.0543.9242.94
Deferred Tax Liabilities7.749.316.819.5910.1011.39
Other Liabilities187.38214.56157.74191.84126.64111.17
Total Liabilities1,341.051,315.541,305.031,406.071,400.351,383.86
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,372.071,325.321,211.331,199.991,157.231,122.84
Total Shareholders Equity1,372.071,325.321,211.331,199.991,157.231,122.84
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity1,372.071,325.321,211.331,199.991,157.231,122.84
Total Liabilities & Stockholders Equity2,713.122,640.862,516.352,606.052,557.582,506.70
Book Value Per Share24.9124.0722.0621.9621.1920.57
Tangible Book Value Per Share6.945.983.663.242.411.65
Full-Time Employees---3,300--
Price to Book Ratio3.663.732.892.902.552.37
Return on Assets7.447.334.22-9.49-8.56-8.52
Return on Equity15.5015.409.54-19.24-17.63-17.87
Return on Invested Capital2.006.521.441.941.731.79
Quick Ratio1.221.211.111.161.121.09
Current Ratio1.461.451.331.361.331.29

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income34.29108.5722.2930.9126.7827.16
Depreciation17.7918.2015.6014.7115.2115.04
Other Funds (Non Cash)0.7149.8235.8024.3030.4113.76
Funds from Operations55.8484.8275.5166.3173.7156.48
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital17.82-18.23-60.2916.0911.356.45
Income Taxes Payable-2.35-10.611.719.98-12.68-6.83
Cash from Operating Activities73.6666.5915.2282.4085.0662.92
Capital Expenditures-30.77-31.55-14.29-32.23-22.88-15.15
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.007.280.000.00
Purchase or Sale of Investments6.950.000.00-5.670.006.52
Purchase of Investments-2.120.000.00-5.670.000.00
Sale Or Maturity of Investments9.070.000.000.000.006.52
Other Uses0.66-0.37-0.290.36-0.18-0.18
Other Sources0.060.000.000.000.00-0.16
Cash from Investing Activities-23.11-31.92-14.58-30.26-23.06-8.97
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-11.720.000.00-0.800.29-3.88
Repurchase of Common Pref Stock-11.720.000.00-0.810.26-3.88
Sale of Common Pref Stock0.000.000.000.000.030.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.00-95.94-64.11-6.56-205.88
Change in Long Term Debt0.000.00-95.94-64.11-6.56-205.88
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.00-95.94-64.11-6.56-205.88
Net Financing Active Other Cash Flow8.81-56.451.692.03-3.100.77
Other Financing Activities Uses4.33-54.760.002.03-2.370.05
Cash from Financing Activities-2.92-56.45-94.25-62.88-9.37-208.98
Exchange Rate Effect-0.79-1.31-2.240.22-0.1910.23
Net Change in Cash46.85-23.09-95.85-10.5352.44-144.80
Free Cash Flow42.8935.040.9350.1662.1847.77
Price to Free Cash Flow34.0231.2022.0819.7115.0915.19

Revenue breakdown

Consolidation, Policy2024: -48.90M 2025: -55.90M
Europe2024: 220.03M 2025: 269.18M
Locations Excluding The United States And Europe2024: 338.32M 2025: 379.30M
United Kingdom2024: 48.90M 2025: 55.90M
United States2024: 695.08M 2025: 739.57M
Cardiopulmonary2024: 683.51M 2025: 785.39M
Consolidation, Policy2024: 15.70M 2025: 9.86M
Neuromodulation2024: 554.22M 2025: 592.81M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3011.60%6.4M54.9M643.77K
2026-10-1511.30%6.2M54.9M645.27K
2026-09-3010.94%6.0M54.9M643.11K
2026-09-159.80%5.4M54.9M670.72K
2026-08-319.09%5.0M54.9M703.13K
2026-08-148.61%4.7M54.9M720.28K
2026-07-317.55%4.1M54.9M751.94K
2026-07-157.47%4.1M54.7M789.71K
2026-06-307.20%3.9M54.7M819.23K
2026-06-156.33%3.5M54.6M794.81K
2026-05-296.10%3.3M54.7M828.98K
2026-05-156.12%3.3M54.7M899.41K
2026-04-306.18%3.4M54.7M840.31K
2026-04-155.86%3.2M54.5M823.82K
2026-03-315.47%3.0M54.5M797.18K
2026-03-135.11%2.8M54.5M738.09K
2026-02-274.40%2.4M54.5M674.15K
2026-02-133.73%2.0M54.4M595.70K
2026-01-304.48%2.4M54.4M611.14K
2026-01-153.37%1.8M54.4M583.37K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call50.0039.1042.500.003.1450.000.000.949-0.2220.015
call55.0034.3037.300.002.6670.000.000.941-0.2150.017
call60.0029.1032.600.002.3780.000.000.932-0.2080.019
call65.0024.3027.300.001.9520.000.000.899-0.2650.025
call67.5021.9024.900.001.8230.000.000.891-0.2580.027
call70.0019.6022.000.001.4880.000.000.881-0.2500.028
call72.5017.0019.800.001.5060.000.000.869-0.2400.030
call75.0014.7017.100.001.2530.000.000.855-0.2300.032
call77.5012.1014.900.001.1870.000.000.839-0.2180.035
call80.009.7012.500.001.0840.000.000.816-0.2040.038
call82.506.709.702.900.8401.000.000.789-0.1910.041
call85.004.908.502.280.9415.000.000.738-0.1880.046
call87.504.105.506.500.6742.000.000.653-0.1940.053
call90.002.703.503.500.5708042.000.544-0.1960.056
call92.501.802.552.200.60116.004.000.432-0.1970.056
call95.000.002.251.900.70265.000.000.363-0.2220.053
call97.500.052.201.210.82611.000.000.310-0.2320.050
call1000.500.800.650.6331,59324.000.173-0.1300.036
call1050.300.350.300.6631,61232.000.085-0.0820.022
call1100.001.000.320.8061.000.000.072-0.0880.020
call1150.001.150.200.94717.000.000.063-0.0930.018
call1200.000.950.001.1440.000.000.073-0.1260.020
call1250.002.150.001.1940.000.000.052-0.1010.015
call1300.002.150.001.3030.000.000.049-0.1050.014
call1350.002.150.001.4090.000.000.046-0.1070.014
call1400.002.150.001.5090.000.000.043-0.1100.013
call1450.002.150.001.6040.000.000.041-0.1120.013
put50.000.002.100.002.6520.000.00-0.051-0.2170.015
put55.000.000.950.352.2962.000.00-0.059-0.2110.017
put60.000.000.950.651.9671.000.00-0.068-0.2030.019
put65.000.002.100.651.8761.000.00-0.101-0.2600.025
put67.500.001.750.001.7000.000.00-0.110-0.2500.027
put70.000.002.100.751.5601.000.00-0.119-0.2440.028
put72.500.002.101.501.4073.000.00-0.131-0.2340.030
put75.000.001.952.401.2618060.00-0.143-0.2230.032
put77.500.002.150.001.1120.000.00-0.160-0.2120.035
put80.000.001.800.470.9587.000.00-0.182-0.1980.038
put82.500.002.400.000.8080.000.00-0.210-0.1820.041
put85.000.351.452.700.6553.000.00-0.262-0.1790.046
put87.501.052.200.000.6400.000.00-0.343-0.1840.052
put90.001.803.402.500.6529.000.00-0.454-0.1860.056
put92.503.404.800.000.6680.000.00-0.561-0.1870.056
put95.003.907.405.000.8434.000.00-0.637-0.2110.053
put97.507.108.800.000.7810.000.00-0.691-0.2210.050
put1008.1011.700.000.9820.000.00-0.827-0.1180.036
put10513.2016.500.001.1660.000.00-0.915-0.0700.022
put11017.7021.400.001.3510.000.00-0.928-0.0760.020
put11522.9025.900.001.4050.000.00-0.931-0.0900.019
put12027.9030.900.001.5670.000.00-0.937-0.0940.018
put12532.9035.900.001.7150.000.00-0.911-0.1630.023
put13037.6041.300.001.9570.000.00-0.917-0.1690.022
put13542.7046.100.002.0600.000.00-0.949-0.1030.015
put14047.7051.100.002.1470.000.00-0.957-0.0940.013
put14552.5056.100.002.3310.000.00-0.954-0.1070.014

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10SCHEDULE 13GSEC
2026-11-05SCHEDULE 13G/ASEC
2026-11-04IRANNOTICENotice of Iran-related disclosure filed pursuant to Section 13(r)(3) of the Exchange ActSEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-10144Filing for proposed sale of securities under Rule 144.SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-04144Filing for proposed sale of securities under Rule 144.SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-09-024Statement of changes in beneficial ownership of securities2026-08-31SEC
2026-09-023Initial statement of beneficial ownership of securities2026-08-31SEC
2026-08-31144Filing for proposed sale of securities under Rule 144.SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-11144Filing for proposed sale of securities under Rule 144.SEC
2026-08-06SCHEDULE 13GSEC
2026-08-05IRANNOTICENotice of Iran-related disclosure filed pursuant to Section 13(r)(3) of the Exchange ActSEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-053Initial statement of beneficial ownership of securities2026-08-01SEC
2026-08-058-KCurrent report2026-08-05SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-0900460.30K2
2026-0800339.48K2
2026-070000
2026-060096.23K1
2026-0500136.35K1
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110013.49K1

Institutional holders

Manager% owned
PICTON MAHONEY ASSET MANAGEMENT18.20%
ABSOLUTE INVESTMENT ADVISERS, LLC14.52%
BlackRock, Inc.13.77%
TPG GP A, LLC13.65%
PRIMECAP MANAGEMENT CO/CA/7.59%
FMR LLC7.22%
Hood River Capital Management LLC4.67%
AQR CAPITAL MANAGEMENT LLC4.29%
Invesco Ltd.4.07%
Artisan Partners Limited Partnership4.05%

Funds

Fund% owned
ABSOLUTE CONVERTIBLE ARBITRAGE FUND14.56%
iShares Convertible Bond ETF12.80%
Columbia Convertible Securities Fund12.71%
Miller Market Neutral Income Fund10.92%
Fidelity Convertible Securities Fund4.73%
VANGUARD CAPITAL OPPORTUNITY FUND3.46%
iShares Core S&P Mid-Cap ETF3.42%
Invesco Small Cap Value Fund3.06%
Avantis U.S. Small Cap Value ETF2.93%
iShares Russell 2000 ETF2.63%

OakChart. LIVN. Cached 15 minutes.